โณ Fetching live dividend data...
Home โบ Calculator โบ HAE Dividend Calculator 2026
Haemonetics Corporation ยท NYSE
Price: $118.51 ยท Annual div: None ยท Frequency: โ ยท Payout ratio: N/A ยท Ex-div: โ
HAE is not a dividend-focused stock
HAE pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Haemonetics Corporation (HAE) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
No. Haemonetics Corporation (HAE) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. HAE has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data ยท open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. ยท Privacy Policy
Ready to invest? Open HAE position with:
Real after-tax yield depends on where you live and how you hold HAE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| ๐บ๐ธ Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| ๐บ๐ธ US Taxable (15%) โ | 15% | 0.00% | -2.80% | $0 / yr |
| ๐บ๐ธ US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| ๐ฌ๐ง UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| ๐ฌ๐ง UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| ๐จ๐ฆ TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| ๐จ๐ฆ CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| ๐ฆ๐บ Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| ๐ฆ๐บ AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| ๐ฉ๐ช DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| ๐ซ๐ท FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr ยท ๐บ๐ธ US Taxable (15%) ยท static projection (no growth assumed).
HAE pays quarterly โ 4 times per year. Ex-div: โ.
How HAE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024โ2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HAE sourced from FMP /financial-growth endpoint โ real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| A-Award | 2026-07-24 | 2,538 | โ | โ | ||
| F-InKind | 2026-06-05 | 259 | $71.28 | $18.5K | ||
| F-InKind | 2026-06-05 | 313 | $71.28 | $22.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Compare HAE with peers: HAE vs BEAM ยท HAE vs BHC ยท HAE vs CON
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores โ lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HAE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer โ
Haemonetics Corporation (HAE) is currently trading at $118.51, trading near its 52-week high. It does not currently pay a regular dividend.
Haemonetics Corporation (HAE) is a healthcare stock trading at $118.51. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only โ not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
โฑ๏ธ Takes 30 seconds ยท No signup ยท Free forever